This week, a need for better access to diagnostic technologies for Long COVID, Iterium Therapeutics’ discussed their FDA-approved Orlynvah for uncomplicated UTIs, the recent rise in human cases of avian influenza, and more.



Source link

Please leave this field empty

Daily Dose of Insights

Get a daily infusion of knowledge with our latest blog updates.

We don’t spam! Read our privacy policy for more info.

Check your inbox or spam folder to confirm your subscription.